| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Jul―30 |
Analyzing the influence of COVID-19 on influenza activity in Fujian Province (2020-2023): A regression discontinuity study |
Hong-Jin Li, Yan-Hua Zhang, Yu-Wei Weng |
| 2 |
[GO] |
2025―May―25 |
Molecular docking and molecular dynamics studies of major phytoconstituents of Nilavembu Kudineer against COVID-19 protein targets |
Sampathkumar Ranganathan, Marie Victoria Rani Auroquiaraj, Ramya Chandra Charles Mariasoosai, Chitra Balasubramanian, Chandramohan Batrachalam |
| 3 |
[GO] |
2024―Aug―23 |
Anti-corisin immunotherapy: therapeutic perspective for reducing the risk of developing COVID-19 coagulopathy? |
Lippi Giuseppe |
| 4 |
[GO] |
2023―Aug―24 |
Epidemiology of COVID-19 in patients referred to health centers in the Nahavand city, western Iran |
Khodayar Oshvandi, Maryam Soori, Sima Hashemi, Manoochehr Solgi |
| 5 |
[GO] |
2023―Aug―08 |
Analysis of factors related to postoperative pulmonary infection in lung cancer patients after recovery from COVID-19 |
Ling Wang, Hai-Ling Li, Li-Zhen Qin, Cai-Xia Liu |
| 6 |
[GO] |
2023―May―10 |
Cytokines Activation kinetics in lung due to COVID-19 infection |
Abbas Zabihi, Sanaz Pashapour, Yeganeh Hamidi, Sahar Saki, Zahra Ghazazani |
| 7 |
[GO] |
2023―Mar―09 |
Pooled analysis of efficacy of the fourth mRNA-based COVID-19 vaccine dose in eliciting anti-SARS-CoV-2 serum antibody response in the general immunocompetent population |
Giuseppe Lippi, Camilla Mattiuzzi, Brandon Michael Henry |
| 8 |
[GO] |
2023―Feb―15 |
The impact of COVID-19 on the birth rate in Nigeria: A report from population-based registries |
Charlotte Blanche Oguejiofor, Kenechi Miracle Ebubechukwu, George Uchenna Eleje, Emmanuel Onyebuchi Ugwu, Joseph Tochukwu Enebe, Kingsley Emeka Ekwuazi, Chukwuemeka Chukwubuikem Okoro, Boniface Chukwuneme Okpala, Charles Chukwunomunso Okafor, Nnanyelugo Chima Ezeora, Emeka Ifeanyi Iloghalu, Chidebe Christian Anikwe, Chigozie Geoffrey Okafor, Polycarp Uchenna Agu, Emeka Philip Igbodike, Iffiyeosuo Dennis Ake, Arinze Anthony Onwuegbuna, Osita Samuel Umeononihu, Onyedika Promise Anaedu, Odigonma Zinobia Ikpeze, David Chibuike Ikwuka, Henry Ifeanyi Nwaolisa Nwaolisa, Ekene Agatha Emeka, Jude Ogechukwu Okoye, Ihechinyerem Kelechi Osuagwu, Angela Ogechukwu Ugwu, Toochukwu Benjamin Ejikeme, Eziamaka Pauline Ezenkwele, Chijioke Ogomegbunam Ezeigwe, Malarchy Ekwunife Nwankwo, Gerald Okanandu Udigwe, Joseph Ifeanyichukwu Ikechebelu, Grace Agbaeze, Chukwuebuka Divine Nwanja, Ahizechukwu C. Eke |
| 9 |
[GO] |
2023―Jan―11 |
Harmonization of SARS-CoV-2 antigen immunoassays: are they measuring the same “thing”? |
Giuseppe Lippi, Gian Luca Salvagno, Gianluca Gianfilippi, Brandon Michael Henry |
| 10 |
[GO] |
2023―Jan―11 |
A mini review and hypothesis for coronavirus detection using photonics: surface enhanced Raman scattering and fluorescence resonance energy transfer |
Akshat Dharmeshkumar Modi, Austin Tian Yang, Akriti Sharma |
| 11 |
[GO] |
2022―Dec―07 |
Retrospective analysis of early COVID-19 vaccine efficacy in older individuals receiving primary cycle, first booster and second booster |
Camilla Mattiuzzi, Brandon Henry, Giuseppe Lippi |
| 12 |
[GO] |
2022―Nov―08 |
Predictors and willingness to take COVID-19 vaccine in Nigeria |
Shuaibu Abdullahi Hudu, Sa’adatu Haruna Shinkafi, Ahmed Subeh Alshrari |
| 13 |
[GO] |
2022―Aug―19 |
Why are children and many adults not affected by COVID-19? Role of the host immune response |
Hélène Banoun |
| 14 |
[GO] |
2022―Aug―17 |
The potential role of the “cold chain” in the spread of SARS-CoV-2 |
XunJie Cao, KeYing Fang, NanXi Li, YaPing Li, XuGuang Guo |
| 15 |
[GO] |
2022―Aug―03 |
Molecular mechanism of Herba Eupatorii in treating COVID-19 based on network pharmacology and molecular docking |
XiaoYing Zhao, AnLan Zhao, YuHui Wang, EnWei Yang, Rui Gong, FangWei Wang |
| 16 |
[GO] |
2022―Aug―01 |
Antimicrobial resistance and challenge post COVID-19 infection |
Arash Soltani |
| 17 |
[GO] |
2022―May―11 |
Comparison of epidemiological characteristics COVID-19 Delta variant infection among children in Xi'an and Baoji |
YuQiang Lu, GuoCheng Zhang, Hui Ding, ZhaoLin Shi, ZhiHong Zhang, YuQi Hao, XinYu Wang, WenJuan Ma, HaiBo Lin, XiaoNing Cheng, NaiRong Gao, Lin Fu |
| 18 |
[GO] |
2022―Apr―29 |
Comparative study between bacterial meningitis vs. viral meningitis and COVID-19 |
Erfaneh Jafari, Reza Azizian, Aram Asareh, Sousan Akrami, Niloofar Karimi |
| 19 |
[GO] |
2022―Apr―06 |
Use of traditional medicine in Algeria as an alternative treatment against COVID-19 in the context of modern medicine: a survey-based study |
Hazar Hamza, Djamila Mokrani, Billal Nia, Abdelkader Touil |
| 20 |
[GO] |
2022―Mar―15 |
Advances in the therapeutic drugs of Coronavirus disease 2019 (COVID-19) |
XingHui Qiao, XiaoMing Zhou, Jiao Guo, XiuLi Guo |
| 21 |
[GO] |
2022―Mar―15 |
The Mechanism of Reduning Injection in the Treatment of COVID-19 associated Myocardial Injury Based on Network Pharmacology and Molecular Docking |
Peng Yuan, Na Zhang |
| 22 |
[GO] |
2022―Mar―15 |
Paying Attention to Special Populations: 1 Case of COVID-19 Asymptomatic Infection with Positive Nucleic Acid and Negative Antibodies in Puerpera |
SiLiang Wu, Chang Chen, XiaoJun Li |
| 23 |
[GO] |
2022―Mar―15 |
Study on the feasibility of Danggui Longhui pill in the treatment of COVID-19 based on network pharmacology |
Hui Huang, YaBin Dai, YongNing Li, Lan Luo, HuaZhen Ye |
| 24 |
[GO] |
2022―Mar―15 |
The difference of clinical characteristics of patients with COVID-19 in Fourth-tier city and Wuhan |
XiaoJuan Wu, ChaoPing Wang, GaoYan He, BaoLin Jia, Li Luo, XiaoBin Luo |
| 25 |
[GO] |
2022―Mar―15 |
The significance of the potential link between thrombocytopenia and NETs in COVID-19 should not be ignored |
XianKun Wang, XingXiang Ren, LiuLuan Zhu, ZhiHai Chen |
| 26 |
[GO] |
2022―Mar―15 |
Molecular Modelling of the Therapeutic agents for COVID-19 Treatment |
Akram Ranjbar, Sara Torabi, Davood Nematollahi, Mahdi Jamshidi, Hadi Ghasemi |
| 27 |
[GO] |
2022―Mar―15 |
Covid-19 vaccines and Community Immunity |
Bhoj R, Sumedha Gandharava, Richa Gandharva |
| 28 |
[GO] |
2022―Mar―15 |
Role of Darunavir/Cobicisitat for treating COVID-19: initial virological and clinical findings |
LiPing Deng, TieLong Chen, YongXi Zhang, MingQi Luo, ShiCheng Gao, PingZheng Mo, ShiHui Song, ZhiYong Ma, XiaoPing Chen, Yong Xiong, HengNing Ke, XingHuan Wang |
| 29 |
[GO] |
2022―Mar―15 |
Covid-19: Thinking Outside the Box To Be Prepared For The Next Pandemic |
Tamer S. |
| 30 |
[GO] |
2022―Mar―15 |
Targeting SARS-CoV-2 main protease for drug discovery |
Yang Liu, KeWu Zeng |
| 31 |
[GO] |
2022―Mar―15 |
A review of the graded treatment strategy for SARS-CoV-2 pneumonia |
QiangQiang Tian, YiFan Liu, Wei Wang, QiMing Zhao, Kai Sheng |
| 32 |
[GO] |
2022―Jan―06 |
Common COVID-19 should be distinguished from acute respiratory infections by other viruses during prehospital treatment |
Chen Li, Lei Wei, JunYuan Tan, XingLong Yang |
| 33 |
[GO] |
2021―Nov―25 |
Cutaneous manifestations during recent pandemic, co-infection or pre or post COVID-19 manifestation -managed by Ayurveda |
Pannaga Samir, Pannaga Samir, Shantala Priyadarshini |
| 34 |
[GO] |
2021―Nov―24 |
Current trends and emerging methods for the detection of SARS-CoV-2 infection |
Mehvish Saleem, Manas Kumar |
| 35 |
[GO] |
2021―Nov―15 |
Genetic variation in coronavirus disease 2019: a literature review |
Sabah Mayahi, Maryam Sadegh, Hadi Koohsari |
| 36 |
[GO] |
2021―Aug―23 |
Elevated levels of the pollutant PM2.5 in crowded subways of cities with high COVID-19 related mortality - when COVID-19 went underground |
Yves Muscat, Liberato Camilleri |
